Announcing the launch of medtronic neurovascular co-lab™ platform to accelerate innovation in stroke treatment

New medtronic neurovascular co-lab™ platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide dublin , oct. 26, 2022 /prnewswire/ -- medtronic plc (nyse: mdt), a global leader in healthcare technology, today announced the launch of medtronic neurovascular co-lab™ platform designed to accelerate urgently needed innovation in stroke care and treatment. the company is harnessing its market-leading position and trusted partner reputation to create a platform that will ultimately advance technology concepts that have the highest potential to positively impact millions of stroke patients.
MDT Ratings Summary
MDT Quant Ranking